R M Slater - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R M Slater

Showing results (61-70 of 66) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 66 results.

Medical and Pediatric Oncology|May 2, 2002

In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.

British Journal of Haematology|March 22, 2001

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemiaN L Ramakers-van Woerden, R Pieters, R M Slater, et al.

Blood|July 27, 2000

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemiaN L Ramakers-van Woerden, R Pieters, A H Loonen, et al.

Leukemia|June 22, 2001

t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disordersR M Slater, E von Drunen, W G Kroes, et al.

Leukemia|February 3, 1998

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.

Leukemia|January 9, 2004

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotypeN L Ramakers-van Woerden, H B Beverloo, A J P Veerman, et al.

Pageof 7

Search research articles

Showing results (61-70 of 66) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 66 results.

Medical and Pediatric Oncology|May 2, 2002

British Journal of Haematology|March 22, 2001

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemiaN L Ramakers-van Woerden, R Pieters, R M Slater, et al.

Blood|July 27, 2000

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemiaN L Ramakers-van Woerden, R Pieters, A H Loonen, et al.

Leukemia|June 22, 2001

t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disordersR M Slater, E von Drunen, W G Kroes, et al.

Leukemia|February 3, 1998

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.

Leukemia|January 9, 2004

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotypeN L Ramakers-van Woerden, H B Beverloo, A J P Veerman, et al.

Pageof 7